POAI New LOGO.jpg
Predictive Oncology Reports Year End 2023 Financial Results and Provides Business Update
March 28, 2024 17:28 ET | Predictive Oncology Inc.
PITTSBURGH, March 28, 2024 (GLOBE NEWSWIRE) -- Predictive Oncology (Nasdaq: POAI), a science driven company leveraging its proprietary artificial intelligence and machine learning capabilities,...
Cielo Logo Full Color RGB 400px@72ppi.png
Cielo Announces Fiscal Q3 2024 Financial Results and Provides Update on its Progress to Fuel Renewable Change
March 28, 2024 17:00 ET | Cielo Waste Solutions Corp.
CALGARY, Alberta, March 28, 2024 (GLOBE NEWSWIRE) -- Cielo Waste Solutions Corp. (TSXV:CMC; OTC:CWSFF) (“Cielo” or the “Company”), a renewable fuel company leveraging market ready licensed...
UNCY Logo.jpg
Unicycive Therapeutics Announces Full Year 2023 Financial Results and Provides Business Update
March 28, 2024 16:15 ET | Unicycive Therapeutics, Inc.
– Oxylanthanum Carbonate (OLC) Topline Data Expected in Q2 2024 – – UNI-494 Granted Orphan Drug Designation in Delayed Graft Function of Acute Kidney Injury – – UNI-494 Phase 1 Single Ascending Dose...
Oxford: Owner of Tommy Bahama, Lilly Pulitzer and Johnny Was Reports Fourth-Quarter and Full-Year Fiscal 2023 Results; Posts 11% Annual Sales Growth; Announces 3% Increase in Quarterly Dividend
March 28, 2024 16:05 ET | Oxford Industries, Inc.
Oxford: Owner of Tommy Bahama, Lilly Pulitzer and Johnny Was Reports Fourth-Quarter and Full-Year Fiscal 2023 Results; Posts 11% Annual Sales Growth
Study Finds Clinicia
Study Finds Clinicians Support Consumers as First Reporters of Early Patient Deterioration in Hospital
March 28, 2024 12:03 ET | The Joint Commission
OAKBROOK TERRACE, Illinois, March 28, 2024 (GLOBE NEWSWIRE) -- Detection of early patient deterioration in the hospital can lead to timely intervention and improved outcomes. Patients themselves, as...
logo.png
Autoimmune Hepatitis Diagnosis and Treatment Market Size to Reach USD 19.15 Bn by 2032
March 28, 2024 11:05 ET | Precedence Research
Ottawa, March 28, 2024 (GLOBE NEWSWIRE) -- The global autoimmune hepatitis diagnosis and treatment market size is calculated at USD 14.33 billion in 2024 and is projected to hit around USD 18.13...
James (Josh) Wilson Faruqi & Faruqi, LLP
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of iRhythm
March 28, 2024 10:55 ET | Faruqi & Faruqi LLP
NEW YORK, March 28, 2024 (GLOBE NEWSWIRE) -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against iRhythm Technologies, Inc. (“iRhythm” or the...
CLS Hopeville Flyer
The Southport CoLAB Community Lecture Series to Host Fairfield County’s Sneak Peek Screening and Panel Discussion for ‘Hopeville: How to Win the Reading Wars’
March 28, 2024 10:45 ET | The Southport School Inc
SOUTHPORT, Conn., March 28, 2024 (GLOBE NEWSWIRE) -- The Southport CoLAB, a resource providing quality education training for professionals, educators, and families to affect positive outcomes for...
abaxx logo.png
Abaxx Announces Closing of C$18,687,500 Bought Deal Financing Including Full Exercise of Over-Allotment Option
March 28, 2024 08:48 ET | Abaxx Technologies Inc.
/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/ TORONTO, March 28, 2024 (GLOBE NEWSWIRE) -- Abaxx Technologies Inc. (CBOE CA:ABXX) (“Abaxx” or...
Logo.png
Ocean Biomedical (NASDAQ: OCEA) Congratulates JV Partner, Virion Therapeutics, on Promising First-Ever Human Phase 1B Clinical Safety Data for Their Lead Checkpoint Modifier-Containing Immunotherapy for HBV Functional Cure, at Global APASL
March 28, 2024 08:01 ET | Ocean Biomedical, Inc.
Providence, RI, March 28, 2024 (GLOBE NEWSWIRE) -- Ocean Biomedical, Inc. (NASDAQ: OCEA), a biopharma company working to accelerate the development of compelling discoveries from top research...